PharmaVoice
pharmavoice.com
Health & Medical Media
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry.PharmaVoice is a leading industry publication operated by Industry Dive. Our stories spark ideas and shape agendas for 5+ million decision makers in the most competitive industries.
News
Trump reportedly plans to tap policy aide Overton to lead FDA
Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.
Read more
Report
How cost and perception could reshape the GLP-1 market
As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.
Read more
Report
How Helus' new CEO plans to scale its psychedelic drug pipeline
Can Michael Halstead replicate the controlled growth he pulled off at Intra-Cellular Therapies in mental health's psychedelic era?
Read more
Report
FDA nod is just the first hurdle for Moderna's potential blockbuster flu vax
Strain selection timing and mRNA skepticism could limit the impact of Moderna's game-changing mRNA flu shot.
Read more
Report
BMS builds big in Texas; Regeneron backs would-be rival
BMS reveals plans for a new manufacturing hub in Houston, and Regeneron invests in startup developing a Dupixent competitor.
Read more
Report
BioNTech's oncology pivot comes with a new CEO
Guido Oelkers will inherit a deep cancer pipeline, declining vaccine sales and $19 billion to fund the transition.
Read more
Report
Biotech initiatives pick up as more regions race to become hubs
New government funding from Pennsylvania to Kansas City is strengthening biotech hubs - but experts say money alone won't determine where pharma builds next.
Read more
Report
Formation Bio taps Biogen, Pfizer alum to tackle R&D's 'boring middle'
Dr. Michael Ehlers bets AI can ease the clinical-development bottleneck - but scaling Formation Bio's pipeline will also require human judgment.
Read more
Report
Drugs that missed the mark in pharma's last earnings round
Why treatments from Alnylam, Merck, AbbVie and Roche stumbled in the last quarter.
Read more
Report
Trump signs order seeking to upend childhood vaccine schedule
The executive order - which wasn't accompanied by any new scientific evidence - aims to split the MMR vaccine into three separate shots and revives the administration's attempt to slim down the immunization schedule.
Read more
Report
Show more news